The Effect of Mindfulness Meditation on Impulsivity and its Neurobiological Correlates in Healthy Adults.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 08 2019
Historique:
received: 29 06 2018
accepted: 11 07 2019
entrez: 21 8 2019
pubmed: 21 8 2019
medline: 3 11 2020
Statut: epublish

Résumé

Interest has grown in using mindfulness meditation to treat conditions featuring excessive impulsivity. However, while prior studies find that mindfulness practice can improve attention, it remains unclear whether it improves other cognitive faculties whose deficiency can contribute to impulsivity. Here, an eight-week mindfulness intervention did not reduce impulsivity on the go/no-go task or Barratt Impulsiveness Scale (BIS-11), nor produce changes in neural correlates of impulsivity (i.e. frontostriatal gray matter, functional connectivity, and dopamine levels) compared to active or wait-list control groups. Separately, long-term meditators (LTMs) did not perform differently than meditation-naïve participants (MNPs) on the go/no-go task. However, LTMs self-reported lower attentional impulsivity, but higher motor and non-planning impulsivity on the BIS-11 than MNPs. LTMs had less striatal gray matter, greater cortico-striatal-thalamic functional connectivity, and lower spontaneous eye-blink rate (a physiological dopamine indicator) than MNPs. LTM total lifetime practice hours (TLPH) did not significantly relate to impulsivity or neurobiological metrics. Findings suggest that neither short- nor long-term mindfulness practice may be effective for redressing impulsive behavior derived from inhibitory motor control or planning capacity deficits in healthy adults. Given the absence of TLPH relationships to impulsivity or neurobiological metrics, differences between LTMs and MNPs may be attributable to pre-existing differences.

Identifiants

pubmed: 31427669
doi: 10.1038/s41598-019-47662-y
pii: 10.1038/s41598-019-47662-y
pmc: PMC6700173
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11963

Subventions

Organisme : NICHD NIH HHS
ID : P30 HD003352
Pays : United States
Organisme : NIMH NIH HHS
ID : P50 MH084051
Pays : United States
Organisme : NCCIH NIH HHS
ID : P01 AT004952
Pays : United States
Organisme : NICHD NIH HHS
ID : U54 HD090256
Pays : United States

Références

IEEE Trans Biomed Eng. 2008 Sep;55(9):2221-31
pubmed: 18713691
Science. 2015 Jun 12;348(6240):1241-4
pubmed: 26068849
J Pharmacol Exp Ther. 1996 Dec;279(3):1211-9
pubmed: 8968343
Psychol Assess. 2013 Mar;25(1):216-26
pubmed: 23148649
Behav Res Ther. 2012 Jan;50(1):3-12
pubmed: 22137364
J Neurosci. 2012 May 23;32(21):7316-24
pubmed: 22623677
Biol Psychiatry. 2009 Apr 15;65(8):710-3
pubmed: 19121516
J Atten Disord. 2008 May;11(6):737-46
pubmed: 18025249
Neuroimage. 2012 Jan 2;59(1):824-30
pubmed: 21827861
Neuropsychopharmacology. 2002 Nov;27(5):813-25
pubmed: 12431855
Nat Commun. 2014 Nov 04;5:5394
pubmed: 25367437
Neuropsychologia. 2008 Jan 15;46(1):224-32
pubmed: 17850833
J Neurosci. 2012 Jul 4;32(27):9402-9
pubmed: 22764248
Neuroimage. 2000 Jun;11(6 Pt 1):805-21
pubmed: 10860804
Cereb Cortex. 2013 Jul;23(7):1509-16
pubmed: 22645252
Psychopharmacology (Berl). 2012 Jan;219(2):527-36
pubmed: 22169883
Neuroimage. 2014 May 15;92:381-97
pubmed: 24530839
J Neurosci. 2014 Oct 22;34(43):14443-54
pubmed: 25339755
J Neurosci. 2009 Nov 25;29(47):14734-40
pubmed: 19940168
Addict Biol. 2009 Jan;14(1):22-31
pubmed: 18855805
Behav Res Ther. 2009 May;47(5):403-9
pubmed: 19232573
Exp Neurol. 1999 Jul;158(1):214-20
pubmed: 10448434
J Pharmacol Exp Ther. 1991 Nov;259(2):595-600
pubmed: 1682479
Trends Cogn Sci. 2008 Apr;12(4):163-9
pubmed: 18329323
Brain Topogr. 2013 Jul;26(3):479-87
pubmed: 23274773
Med Image Anal. 2001 Jun;5(2):143-56
pubmed: 11516708
Hum Brain Mapp. 2002 Nov;17(3):143-55
pubmed: 12391568
Psychol Sci. 2005 Dec;16(12):939-44
pubmed: 16313657
Clin Psychol Sci. 2016 Sep;4(5):760-774
pubmed: 27833790
Psychiatry Res. 2000 Mar 6;93(2):145-51
pubmed: 10725531
Emotion. 2011 Apr;11(2):299-312
pubmed: 21500899
Neuroimage. 2017 Aug 15;157:288-296
pubmed: 28602816
Pharmacol Biochem Behav. 1991 Apr;38(4):869-74
pubmed: 1678527
Comput Biomed Res. 1996 Jun;29(3):162-73
pubmed: 8812068
Neurology. 1984 May;34(5):677-8
pubmed: 6231489
Soc Cogn Affect Neurosci. 2017 Jun 1;12(6):1001-1008
pubmed: 28402539
Nat Neurosci. 2005 Nov;8(11):1450-7
pubmed: 16251987
Ann Neurol. 1982 Dec;12(6):580-3
pubmed: 7159063
Cogn Affect Behav Neurosci. 2007 Jun;7(2):109-19
pubmed: 17672382
Cereb Cortex. 2014 Apr;24(4):935-44
pubmed: 23242198
J Neurosci. 2011 Aug 3;31(31):11256-67
pubmed: 21813686
Neuroimage. 2002 Oct;17(2):825-41
pubmed: 12377157
Cereb Cortex. 2008 Dec;18(12):2735-47
pubmed: 18400794
Adv Neurol. 1988;49:25-37
pubmed: 2964173
J Neurosci. 2015 Apr 15;35(15):5990-7
pubmed: 25878272
J Neurosci. 2013 Mar 13;33(11):4886-95
pubmed: 23486959
Neuroimage. 2007 Oct 15;38(1):95-113
pubmed: 17761438
J Clin Psychol. 1995 Nov;51(6):768-74
pubmed: 8778124
Psychophysiology. 2016 May;53(5):749-58
pubmed: 26871460
Psychol Assess. 2016 Aug;28(8):1009-14
pubmed: 26460893
Exp Brain Res. 2009 Jul;196(3):467-74
pubmed: 19484465
Eur J Neurosci. 2009 Apr;29(7):1522-32
pubmed: 19519632
Hum Brain Mapp. 2009 Apr;30(4):1188-95
pubmed: 18465751
Appetite. 2011 Apr;56(2):241-8
pubmed: 21146571
Subst Abus. 2009 Oct-Dec;30(4):266-94
pubmed: 19904664
J Pharmacol Exp Ther. 2004 Dec;311(3):1008-15
pubmed: 15292458
J Neurosci. 2016 Apr 6;36(14):4038-49
pubmed: 27053210
Psychol Assess. 2013 Jun;25(2):631-42
pubmed: 23544402

Auteurs

Cole Korponay (C)

Department of Psychiatry, University of Wisconsin-Madison, Madison, Wisconsin, 53719, USA.
Center for Healthy Minds, University of Wisconsin-Madison, Madison, Wisconsin, 53703, USA.

Daniela Dentico (D)

Department of Psychiatry, University of Wisconsin-Madison, Madison, Wisconsin, 53719, USA.
Center for Healthy Minds, University of Wisconsin-Madison, Madison, Wisconsin, 53703, USA.
Waisman Laboratory for Brain Imaging and Behavior, University of Wisconsin-Madison, Madison, Wisconsin, 53705, USA.

Tammi R A Kral (TRA)

Department of Psychology, University of Wisconsin-Madison, Madison, Wisconsin, 53706, USA.
Center for Healthy Minds, University of Wisconsin-Madison, Madison, Wisconsin, 53703, USA.
Waisman Laboratory for Brain Imaging and Behavior, University of Wisconsin-Madison, Madison, Wisconsin, 53705, USA.

Martina Ly (M)

Center for Healthy Minds, University of Wisconsin-Madison, Madison, Wisconsin, 53703, USA.
Waisman Laboratory for Brain Imaging and Behavior, University of Wisconsin-Madison, Madison, Wisconsin, 53705, USA.

Ayla Kruis (A)

Center for Healthy Minds, University of Wisconsin-Madison, Madison, Wisconsin, 53703, USA.
Waisman Laboratory for Brain Imaging and Behavior, University of Wisconsin-Madison, Madison, Wisconsin, 53705, USA.
University of Amsterdam, 1012 WX, Amsterdam, Netherlands.

Kaley Davis (K)

Center for Healthy Minds, University of Wisconsin-Madison, Madison, Wisconsin, 53703, USA.

Robin Goldman (R)

Center for Healthy Minds, University of Wisconsin-Madison, Madison, Wisconsin, 53703, USA.
Waisman Laboratory for Brain Imaging and Behavior, University of Wisconsin-Madison, Madison, Wisconsin, 53705, USA.

Antoine Lutz (A)

Lyon Neuroscience Research Center, Brain Dynamics and Cognition Team, INSERM U1028, CNRS UMR5292, Lyon 1 University, Lyon, France.
Center for Healthy Minds, University of Wisconsin-Madison, Madison, Wisconsin, 53703, USA.
Waisman Laboratory for Brain Imaging and Behavior, University of Wisconsin-Madison, Madison, Wisconsin, 53705, USA.

Richard J Davidson (RJ)

Department of Psychiatry, University of Wisconsin-Madison, Madison, Wisconsin, 53719, USA. rjdavids@wisc.edu.
Department of Psychology, University of Wisconsin-Madison, Madison, Wisconsin, 53706, USA. rjdavids@wisc.edu.
Center for Healthy Minds, University of Wisconsin-Madison, Madison, Wisconsin, 53703, USA. rjdavids@wisc.edu.
Waisman Laboratory for Brain Imaging and Behavior, University of Wisconsin-Madison, Madison, Wisconsin, 53705, USA. rjdavids@wisc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH